(HFIN) Hamilton Enhanced Canadian - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA4073641082

Financial Stocks, Canadian Banks, Investment Firms, Insurance Companies

Description: HFIN Hamilton Enhanced Canadian

The Hamilton Enhanced Canadian Financials ETF (HFIN) is designed to provide amplified exposure to the Canadian financial services sector by tracking 1.25 times the Solactive Canadian Financials Equal-Weight Index TR. This index comprises an equal weighting of the top 12 largest Canadian financial services companies, thereby diversifying the investment within the sector. To further enhance growth potential and yield, the ETF utilizes a modest 25% cash leverage.

From a performance perspective, HFIN has shown a positive trend, as indicated by its moving averages (SMA20: $21.35, SMA50: $20.78, SMA200: $19.29). The ETFs last price is $21.75, near its 52-week high of $21.80, suggesting strong recent performance. The Average True Range (ATR) of 0.17, or 0.76%, indicates relatively moderate volatility.

Key Performance Indicators (KPIs) to monitor for HFIN include its tracking error relative to the Solactive Canadian Financials Equal-Weight Index TR, the impact of leverage on its returns, and the overall health of the Canadian financial services sector. The ETFs Assets Under Management (AUM) stand at $239.34M CAD, indicating a reasonable scale. Investors should also consider the expense ratio and how it affects net returns. Given its focus and leverage, HFIN may be more suited to investors with a higher risk tolerance seeking exposure to the Canadian financial sector.

To evaluate HFINs potential, its essential to analyze the underlying indexs constituent stocks, their financial health, and the macroeconomic factors influencing the Canadian financial services sector. The equal-weighting approach can help mitigate the risk associated with any single stock, but the use of leverage amplifies both potential gains and losses. Therefore, understanding the sectors outlook and the ETFs management strategy is crucial for making informed investment decisions.

Additional Sources for HFIN ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

HFIN ETF Overview

Market Cap in USD 181m
Category Alternative Equity Focused
IPO / Inception 2022-01-26

HFIN ETF Ratings

Growth Rating 65.2
Fundamental -
Dividend Rating 59.3
Rel. Strength 20.6
Analysts -
Fair Price Momentum 22.35 CAD
Fair Price DCF -

HFIN Dividends

Dividend Yield 12m 4.07%
Yield on Cost 5y 6.33%
Annual Growth 5y 3.28%
Payout Consistency 98.8%
Payout Ratio %

HFIN Growth Ratios

Growth Correlation 3m 95.8%
Growth Correlation 12m 82.9%
Growth Correlation 5y 83.4%
CAGR 5y 15.31%
CAGR/Max DD 5y 0.58
Sharpe Ratio 12m 2.48
Alpha 33.43
Beta 0.538
Volatility 14.23%
Current Volume 12.5k
Average Volume 20d 5.4k
Stop Loss 20.9 (-2.8%)
What is the price of HFIN shares?
As of August 02, 2025, the stock is trading at CAD 21.51 with a total of 12,523 shares traded.
Over the past week, the price has changed by -2.71%, over one month by +0.27%, over three months by +11.21% and over the past year by +40.00%.
Is Hamilton Enhanced Canadian a good stock to buy?
Yes. Based on ValueRay's Analyses, Hamilton Enhanced Canadian (TO:HFIN) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.20 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HFIN is around 22.35 CAD . This means that HFIN is currently overvalued and has a potential downside of 3.91%.
Is HFIN a buy, sell or hold?
Hamilton Enhanced Canadian has no consensus analysts rating.
What are the forecasts for HFIN share price target?
According to our own proprietary Forecast Model, HFIN Hamilton Enhanced Canadian will be worth about 25.3 in August 2026. The stock is currently trading at 21.51. This means that the stock has a potential upside of +17.76%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.3 17.8%